ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[STARD13, TBXA2R, ROCK2, TEK, THBS1, GTF2I, CCR2]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[PDGFRB, RRM1, SFRP1, RNF38, H3F3A, KIT, SOX8, MEA1]
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[IL23A, PDCD1LG2, AGER]
GO:0035162;embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;36.11381869205153;6.832634648514029;0.0012086970112962418;0.6725415662651573;[KIT, FLT3LG, STK3]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[NLRP12, IL23A, SPHK1, ZFP91, TNFRSF10B, TNFRSF10A, CCL19, AGER, RELA, LIMS1, HAVCR2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[PDGFRB, SMG1, CD80, IMPAD1, KIT, ZFYVE21, PIK3C3, MET, VAV1, HBEGF]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, CRTC2, ITGB2, CEBPG, CIB1, NLRC4, LRP8, AGER, RELA, STK3, MTDH, RPS6KA4, RPS6KA5, EP300, NLRP3, RIPK1, CYTL1, UBE2I, BUD31, SPHK1, TMEM173, PPRC1, NFKB1, IL6, COPS5, KIT, TRIM14, KRAS, TRIM32, ARHGEF5, CARD11]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, SPHK1, ITGB2, CIB1, NLRC4, AGER, NFKB1, RELA, MTDH, RPS6KA4, RPS6KA5, TRIM14, NLRP3, RIPK1, KRAS, TRIM32, CARD11]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[MAP3K3, XBP1, SPHK1, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, PDCL3, RRAS, SP1, TBXA2R, CTSH, TEK, EPHA1]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[ERN1, P2RX7, DUSP5, KARS, PDE6H, TAOK2, KIT, RIPK1, CCL19, THBS1, MAPK8IP3]
GO:0009308;amine metabolic process;4.0;0.5295311121456219;0.5147655560728109;6.961296045910167;23.636994252021474;5.649939242635378;7.911089257014214E-4;0.5389381556174175;[SULT1A1, AOC3, MOXD1, ABCC2, AMD1, ATP7A, ALDH7A1, AGMAT, SRM]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, IKZF1, IKZF2, YY1, RPS6KA5, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, ZBTB32, HCFC2, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, XRCC5, WFS1, NONO, CAV1, H3F3A, NFKB1, CNOT7, CDK5, QARS, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, OTUD7B, BRCA1, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, DEPDC1, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, LIMS1]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ENDOG, ELL, UBE2B, ANGPT1, RIC8A, FLCN, CCNB1, FUT8, RXRA, ALS2, SIN3A, MAFF, CCM2, SOX8, EIF4E2, ATP7A, APBA3, SOX6, SEC24C]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, ZNF175, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, YEATS4, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, NOLC1, RLF, SUPT6H, HSPH1, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, PKD2, WDR43, CKS1B, FLCN, NIPBL, LBH, SIN3A, NUP62, HRAS, ZNF485, SEC13, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, ZFP90, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MAPRE3, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIA, NFIB, TNIP2, TTC5, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1, MIXL1]
GO:0031110;regulation of microtubule polymerization or depolymerization;8.0;0.7248374789738407;0.7374187394869203;9.117698628726131;35.502556834779206;5.4730085344763;0.001188238627033293;0.6548899109740429;[FES, CIB1, MAPRE3, MAPRE1, MET, CLASP1, EML2]
GO:2000352;negative regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.9263443150347;6.444869117505266;0.0043485178181058145;0.7258315315665724;[FGA, ANGPT1, TNIP2, FGG, TEK]
GO:2001200;positive regulation of dendritic cell differentiation;8.0;1.0;0.875;9.628524252492122;348.5925401978186;8.390779266560578;0.011667078607502778;0.8041048419030481;[AGER]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[CDK5, FES, TEK, HRAS]
GO:0002371;dendritic cell cytokine production;4.0;0.8933024483968273;0.6966512241984136;9.405380701177911;31.58806594444361;9.777073627680469;0.0010572241397468415;0.75;[KIT]
GO:1902686;mitochondrial outer membrane permeabilization involved in programmed cell death;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;63.24701028313514;7.292166977892469;0.0021168205155627476;0.747921758369865;[RHOT2, RHOT1, EYA2, PPIF, BID]
GO:0043114;regulation of vascular permeability;5.0;0.8436909121759173;0.712086467948879;9.176539128749065;21.1969122232846;6.343086423195323;7.094415761308522E-4;0.6146267465268138;[BCR, ABR, ANGPT1, TEK]
GO:0008354;germ cell migration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.540081573954176;7.57984905034425;0.0013568400465755524;0.6778748447945537;[KIT]
GO:1902445;regulation of mitochondrial membrane permeability involved in programmed necrotic cell death;7.0;1.0;0.8509193652572005;9.628524252492122;52.52727335290614;8.67846133901236;0.001758040567644875;0.7947362817240173;[PPIF]
GO:0043116;negative regulation of vascular permeability;6.0;1.0;0.8231203125901445;9.628524252492122;22.58320658440663;7.379178354882098;7.558396008136816E-4;0.7004918368257019;[ANGPT1]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[TMEM87A, GOSR1, VPS52, STX5, VPS54, ZFYVE21, VPS26B, RAB6A, PLEKHJ1, BAIAP3]
GO:0051894;positive regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;280.4986055833795;6.599019797332524;0.009388035896519984;0.712474179321389;[SFRP1, TEK, LIMS1, S100A10]
GO:0048014;Tie signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;8.67846133901236;0.0010376185600805164;0.8188169164668168;[ANGPT1, TEK]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[ACTR2, ARPC2, ROCK2, ARPC1A, AP2S1, WASL, EPHA1, EFNA4, HRAS, EPHB4]
GO:0001956;positive regulation of neurotransmitter secretion;8.0;0.7508913569872202;0.7504456784936101;9.33127272902419;367.30173324646773;7.069023426578259;0.012293258461660482;0.7365101867784198;[RAB3GAP1, BAIAP3]
GO:0071243;cellular response to arsenic-containing substance;4.0;0.8653626801206646;0.6826813400603323;9.377209824211215;38.7152913866576;7.138016298065211;0.0012957659612112835;0.6150384854347593;[ZFAND2A, MKNK2, PPIF]
GO:0032793;positive regulation of CREB transcription factor activity;12.0;1.0;0.9481203125901445;9.628524252492122;279.4401483168805;7.004484905440688;0.009352610284359957;0.8063299963962409;[RPS6KA4, CRTC2, RPS6KA5, LRP8]
GO:0120072;positive regulation of pyloric antrum smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;9.777073627680469;0.00375416456595737;0.9152410118609203;[KIT]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, IGFBP5, ANGPT1, CD80, THBS1, VAV1, STK3, MTDH, C1QBP, KIT, CCL19, TEK, MET, HBEGF]
GO:1900272;negative regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;54.24497338163739;7.57984905034425;0.0018155304417768478;0.7838744581139225;[PRNP, AGER]
GO:0043122;regulation of I-kappaB kinase/NF-kappaB signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;4.406435599552807;0.001508456149618737;0.5762646867385423;[ANKRD17, SLC20A1, OTUD7B, RORA, TANK, RELA, MTDH, AKAP13, TFG, UBD, NUP62, RIPK1, CCL19, ECT2, TMED4, MAP3K3, UBE2I, ANGPT1, ZDHHC13, TNFRSF10B, CD4, NLRP12, TNIP2, TRIM32, CARD11]
GO:0045785;positive regulation of cell adhesion;4.0;0.5768751454443798;0.53843757272219;7.230628979693751;21.972203539282862;3.842179432060882;7.353898787604294E-4;0.44648923483520947;[TFRC, DOCK8, CD80, SIRPG, CIB1, FLCN, C1QBP, CTLA4, IL12A, CCR2, HLA-DPA1, HAVCR2, FGA, IL4R, ITGA2, FGG, PDCD1LG2, UNC13D, VAV1, ITPKB, SFRP1, IL23A, EPHA1, CARD11, EBI3, CORO1A, AGER, HLA-DMB, HSPH1, CCL5, NLRP3, NCKAP1L, CSK, CCL19, IL12RB1, S100A10, XBP1, ANGPT1, PLEKHA2, CAV1, CD4, IL6, CDK6, ARPC2, GPAM, HLA-DPB1, PDCD1, TEK, LIMS1]
GO:0002221;pattern recognition receptor signaling pathway;10.0;0.6467165523344657;0.7385992880281531;8.89455507741192;408.2729656680319;5.049685808968129;0.01366452873909497;0.6734821789659555;[COLEC12, FGA, ITGB2, FGG, TMEM173, TANK, RELA, HSP90B1, NFKBIA, ITCH, TNIP2, CLEC7A, RIPK1, PIK3C3, HAVCR2]
GO:0038093;Fc receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;77.78262967477835;4.556717802602145;0.0026033146153928975;0.5839501255913225;[NCKAP1, ACTR2, FCER1G, WIPF2, ARPC1A, WASL, NFKB1, VAV1, RELA, ARPC2, KIT, ELMO1, NCKAP1L, LCP2, CALM1, CARD11]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CREBBP, FCER1G, RPS6KA5, EP300, KRAS, HRAS, NFKB1, RELA, CARD11]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL4R, IRF4, CLEC7A, BCL3, IL12A, LYST, HRAS]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[KIT, CTSH]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGRP4, PABPN1, CCL5, MYC, CTSH, NCAM1, MBP, RIPK1, HRAS, PDGFRB, MAP3K3, DUSP5, KSR1, ANGPT1, PAQR3, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, KIT, CCM2, KRAS, TEK, CALM1, MET, HBEGF]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, ENDOG, PPIF, CPNE2, ECT2, ARID1A, RASGRP2, TUBG1, PKD2]
GO:0060374;mast cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;47.07409398820286;8.67846133901236;0.0015755275618510598;0.7669372290569613;[KIT]
GO:0090324;negative regulation of oxidative phosphorylation;11.0;0.8653626801206646;0.8651102923899945;9.566003895510788;1056.5785317461448;7.9853141584524145;0.035362732598599886;0.8407982897480031;[PPIF]
GO:0008210;estrogen metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;78.56989776551285;6.599019797332524;0.002629663769894499;0.6605944919115335;[SULT1A1, SGPL1, HSD17B4, COMT, HSD17B8]
GO:0032780;negative regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.329885291612335;7.004484905440688;0.0017179650668126642;0.6813299963962409;[ATPIF1, PPIF]
GO:0090201;negative regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.8116675549172;6.943860283624253;0.015824581010188264;0.7513499630073597;[PRELID1, LMNA, PPIF]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[HRK, PLAUR, PPIF, BID, BBC3]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[PRNP, CDK5, AGER, IGF1R]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[CDKN1C, ERRFI1, CDKN1A, CIB1, PTPN22, DUSP14, IGF1R, FLCN, NNT, MYC, NUP62, PBK, DACT1, DUSP5, PAQR3, SIRT2, DUSP22, SFRP1, NCOR1, CTDSP2, DDIT4, EPHA1, CHMP6, PAFAH1B1, HDAC3, PPP2CA, CCNB1, HSPH1, SNX25, STK38, CSK, PRNP, CDKN2C, UBE2B, AMBP, ANGPT1, CAV1, P2RX7, ITCH, NLRP12, CDK6, QARS, GNAQ, PKIA, TAF7, FGFR1OP, CALM3, CRIPAK, CALM1, CALM2]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, FCER1G, CCL20, CCL5, ITGB2, NCKAP1L, CCL19, VAV1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CXCL6, GYPA, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, CD99L2, LYST, CORO1A, GLG1, CCL5, NCKAP1L, CCL19, CCR2, HSD3B7, FCER1G, ANGPT1, CCL20, CAV1, TNFRSF10B, TNFRSF10A, ATP1B2, VAV1, NLRP12, IL6, COL1A2, KIT, SDC1, TEK, CD244, ARHGEF5]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[PDCL3, SP1, ITGB3, ARNT, TEK]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[ERRFI1, CUEDC2, PPP1R11, OTUD7B, PTPN22, GPATCH3, THBS1, AGER, YY1, RPS6KA4, RPS6KA5, NLRP7, C1QBP, NLRP3, NCKAP1L, CSK, HOMER3, IL12A, HAVCR2, PRNP, LAG3, ANGPT1, PDCD1LG2, NFKB1, ITCH, NLRP12, TWSG1, IL6, NPLOC4, IL23A, BCL3]
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1143.6879814690685;7.212124270218933;0.03827820748741112;0.8169486831672182;[ANGPT1, PILRB]
GO:1904251;regulation of bile acid metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.446202695698167;58.70275173925325;7.292166977892469;0.0019647282716661932;0.7238411236270654;[KIT]
GO:0061890;positive regulation of astrocyte activation;11.0;1.0;0.9324289523296623;9.628524252492122;597.8622644248292;8.67846133901236;0.020009911949193635;0.8762458687964789;[AGER]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[VIL1, DGKD, RPS6KA5, CAMLG, FES, FAM83A, HBEGF]
GO:0061099;negative regulation of protein tyrosine kinase activity;11.0;0.8653626801206646;0.8651102923899945;9.55953138100517;2158.5537617243776;6.481236761676141;0.07224485183265184;0.7638797017301124;[ERRFI1, CAV1, FGFR1OP, CHMP6]
GO:1900453;negative regulation of long term synaptic depression;9.0;1.0;0.896240625180289;9.628524252492122;158.35711283251328;8.67846133901236;0.005300070054355343;0.8400575416471059;[AGER]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[EPHB4]
GO:0000413;protein peptidyl-prolyl isomerization;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;156.19170532668662;6.039404009397101;0.005227595813875556;0.705096027081865;[PPIF, PPID]
GO:0009597;detection of virus;6.0;1.0;0.8231203125901445;9.628524252492122;28.654098265158677;8.16763571524637;9.59026881920657E-4;0.7408135829017477;[SERINC3]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, AHCYL1, RPL3, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TBC1D2B, MYO7A, SYTL3, BCR, NUP93, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, HSP90B1, VPS11, RAB6A, VPS16, PMM1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, HYOU1, ARF3, TRAM1, YWHAB, SRP54, CLTA, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, ARL5A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, ACOX2, AGPS, SLU7, RABGAP1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, SEC24C]
GO:0043303;mast cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;196.3355458728175;7.138016298065211;0.006571174029843636;0.7612791106150483;[KIT]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, RXRA, ALDH5A1, GPX3, IMPDH2, PPAT, ATPIF1, ALDOA, PKD2, ACACA, GLS]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[FANCI, RNF20, ANGPT1, WFS1, SPHK1, CAV1, PTPN22, BRCA1, SENP2, MASTL, UBE2L3, CDK9, FZR1, UBQLN1, SKP2]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, DDX41, ZC3HAV1, LYST, RELA, NLRP3, IFNAR2, APOBEC3F, DTX3L, APOBEC3H, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, SERINC3, APOBEC3A, EXOC1]
GO:2000276;negative regulation of oxidative phosphorylation uncoupler activity;10.0;1.0;0.9152410118609203;9.628524252492122;290.1918223610672;9.083926447120524;0.009712459138740456;0.8797934328124444;[PPIF]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[CREB3, XBP1, HSPH1, WFS1, NONO, SYVN1, PLAUR, PPIF, VDAC2, HYOU1, BID, TRIM32]
GO:0038109;Kit signaling pathway;8.0;1.0;0.875;9.628524252492122;61.193638670852046;9.083926447120524;0.002048096015614107;0.839552420951524;[KIT]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNB1, CCNH, MAPRE3, MNAT1, PKD2, CKS1B]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, HEBP1, AKAP13, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, SPHK2, SPHK1, VAV1, SFRP1, GAL, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, SUCNR1, ROCK2, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, CCL5, CCL19, ECT2, NTSR1, CCR10, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, NMUR1, CALM3, CALM1, CALM2]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[KIT]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB21, RAB3B, RAB43, RAB20, RAB40C, RAB13, RAB18, RAB27B, RAB28, RAB6A, RAB11A, RAB8B]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[PDGFRB, KIT, CCL19, TEK]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, FCER1G, CD163L1, TFRC, AMBP, CAV1, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, AGER, HSP90B1, GAK, CLN3, HSPH1, SYNJ1, SNX17, AP2S1, CD9, HYOU1, APOL1, SCARF1]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[GPAM, IL23A, IL12RB1, AGER]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[ERRFI1, BTG2, OXTR, MAX, CRHR1, RELA, RAP1B, PPAT, NPPA, SCAP, CSK, CYC1, RAB8B, EIF2B4, XBP1, ABCC2, IGFBP5, CAV1, CAD, TSHR, NFKB1, GAL, SP1, MARS, RAB13, TEK]
GO:1904825;protein localization to microtubule plus-end;10.0;0.9326813400603323;0.8815816818910864;9.548481544818586;37.784244099391444;8.67846133901236;0.0012646046463946437;0.8590579283277371;[MAPRE3, MAPRE1]
GO:0072657;protein localization to membrane;5.0;0.5756379274792419;0.5780599756005412;7.585450354983161;29.829169826127035;3.7017275965917853;9.983554695705216E-4;0.4795475332985618;[RAB3B, TRAM1, SYS1, RPL3, NCF1, ITGB2, SRP54, ZDHHC6, ABCA12, TRAM2, GPHN, RPS15, TMED2, ARL5A, RAB8B, GRIPAP1, RPS9, FCER1G, RPS7, SSR2, GAK, CHMP4B, RPL29, VAMP5, ROCK2, ZDHHC23, ZDHHC24, AGER, TM9SF4, RAB40C, BID, RPL19, S100A10, PEX16, BBS2, UBL4A, PEX19, AGK, CAV1, RAB3IP, IFT122, RPL23A, RAB11A, TM9SF1, CDK5, SLMAP, RAB13, TAOK2, RAB3GAP2, RAB3GAP1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ERRFI1, CXCL6, COPA, NCF1, EBI3, IL27, AGER, CCL5, NPPA, IL12A, FAM3C, CCL19, CMTM7, UBE2I, CCL20, CD70, BUD31, FLT3LG, NETO2, IL6, GAL, CDK5, IL23A, CHMP6, KCNK3, HBEGF]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, GRIPAP1, SYS1, FCER1G, ROCK2, ZDHHC23, ABCA12, RAB11A, GAK, RAB40C, SLMAP, RAB13, TMED2, VAMP5, RAB8B, S100A10]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, BRCA1, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, THOP1, HIST1H2BC, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, FZR1, RNF213, RAB40C, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, TSPAN17, KBTBD2, FBXL3, TRIM32, ASB3, KBTBD8]
GO:0035066;positive regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1302.9179711131005;6.444869117505266;0.043607491943109866;0.7620198587159455;[RPS6KA4, RPS6KA5, WBP2, BRCA1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[VAMP8, VPS18, ITCH, GYPA, TFRC, SIVA1, CLDN9, ITGB3, ITGA2, CD80, NUP153, NCAM1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[TBCCD1, WDR1, EPB41, WIPF2, LST1, ITGB2, CDC7, VRK1, VRK2, WASL, CORO1A, VIL1, MKLN1, CFDP1, FES, TAOK2, KIT, ALDOA, CSNK1G2, CSNK1G1]
GO:0042119;neutrophil activation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;20.951462914457938;3.578594911188161;7.012266086544604E-4;0.5061298227699893;[SERPINA3, PYGB, CXCL6, SIGLEC9, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SERPINB6, VAMP8, ACLY, DOCK2, ALDOA, SLC27A2, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, LILRA2, C3, RAP1B, COMMD9, CCL5, PSMB1, NCKAP1L, RAB6A, XRCC6, TMEM30A, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0014002;astrocyte development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.09911675737102;6.832634648514029;0.001141266750656509;0.639662265535933;[CDK6, TSPAN2, KRAS, AGER]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[ITGB2, AGER]
GO:0006068;ethanol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;292.83912655610527;7.292166977892469;0.009801062027729285;0.7238411236270654;[SULT1A1]
GO:0006982;response to lipid hydroperoxide;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;39.75265031464693;8.67846133901236;0.0013304854309686633;0.7340579283277371;[GPX3]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[HERPUD2, HSPH1, DNAJB5, RHBDD1, HSPA6, HSPB3, HSPE1, THBS1]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[CREBBP, MAML1, SLC35C2, TSPAN17, KIT, EP300]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN3, FBXL15, PKMYT1, MASTL, TUBG1, CKAP5, CDC25A, CIT, CCNB1, WEE1, PPME1, CENPJ, CEP70, CDK2, FGFR1OP, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0035855;megakaryocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;66.38585475831493;7.069023426578259;0.0022218748153703875;0.6517511986393402;[KIT, EP300, FLI1]
GO:0033674;positive regulation of kinase activity;9.0;0.6073376606709605;0.6999094555157693;8.620883742029738;265.89784403492143;3.4106031799490317;0.008899361547325376;0.5706590304121504;[CDKN1A, NCF1, CCNH, ITGB3, KIF14, CIB1, PKD2, IGF1R, CKS1B, AKAP13, NEK1, HRAS, EPHB4, PDGFRB, DUSP5, ZFP91, OXSR1, MAPK8IP3, ERN1, KARS, ALS2, IL23A, KIT, JTB, MTCP1, LCP2, MAPRE3, ADNP, EPHA1, MET, ARHGEF5, VAC14, LRP8, THBS1, AGER, STK3, PPP2CA, CCNB1, HSPH1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, ZNF622, CCL19, ECT2, MARK2, MAP3K3, PRNP, XRCC6, PDE6H, ANGPT1, XRCC5, RYK, TNFRSF10B, TNFRSF10A, PILRB, P2RX7, CENPE, CCDC88A, CD4, CDK5, TAOK2, KRAS, CALM3, CAMK1, TEK, CALM1, MNAT1, CALM2, EZH2]
GO:0032228;regulation of synaptic transmission, GABAergic;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;30.61939422688933;6.311337724880743;0.001024803569108247;0.6736814700148209;[USP46, NISCH, OXTR, KRAS, BAIAP3]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[SPAG6, STRBP, H3F3A, KIT, CIB1, AFF4, IQCG]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[PRNP, LAG3, IL4R, ANGPT1, CD80, SWAP70, FGG, GLMN, PTPN22, PDCD1LG2, THBS1, DUSP22, ITCH, TWSG1, ARHGDIB, CD9, CTLA4, MBP, FXYD5, HAVCR2]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[GAK, TOR1A, HSPH1, DNAJC7, DNAJB5, HSPA6, BAG1, HSPE1]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[NCKAP1, OXTR, MAML1, WIPF2, PKD2L1, TIAL1, RPS6KA4, RPS6KA5, GNAT2, MYC, HOMER3, IL12A, EPHB4, CSNK2A1, FLT3LG, HLA-A, HLA-F, RUNX2, BCR, SFRP1, TWSG1, KARS, IL23A, DDIT4, PSME2, EPHA1, EBI3, APCDD1, CRHR1, IL22RA2, MTDH, SGPL1, TSPAN7, TSPAN4, ATP6V0A2, NCKAP1L, TSPAN2, HLA-DQA1, CCR10, BBS2, CREBBP, SIVA1, EIF2AK3, PILRB, PILRA, SETX, COL1A2, SDC1, CALM1, HLA-DRB3, CPEB4, CDKN1A, SIGLEC9, ARPC1A, IL27, WASL, CTLA4, HRAS, CCR2, HLA-DPA1, FCER1G, CAMLG, PARP2, ROM1, PDCD1LG2, BTN3A2, GFRA2, SIRT2, VAV1, DDB1, ITPKB, KIT, TAX1BP3, HBEGF, NOTCH2NL, NEDD9, LILRA2, AKAP2, RELA, PERP, AP2S1, CCL19, BID, IL12RB1, MAP3K3, CCL20, CD70, RYK, G0S2, LILRB3, ITCH, CENPJ, HLA-DPB1, LIMS1, GALNT11, DGKD, NCF1, CD80, IL5RA, CIB1, RORA, IGF1R, ADORA3, NPPA, CFL1, EP300, TLE4, IFNAR2, SEMA6B, PDGFRB, LAG3, IL4R, SLC9A6, CD8B, CCNE1, ELMO1, CSNK1G2, CARD11, CSNK1G1, CD151, DIABLO, DTX2, KLHL12, ADIPOR2, CORO1A, EFNA4, AGER, RASGRP4, HSP90B1, RAP1B, FUT8, BAG3, BAG1, DVL3, RIPK1, MARK2, ATP6V1F, FAM83A, EIF2B4, UBE2B, BTN2A1, IFT122, TNFRSF10B, TNFRSF10A, NFKB1, VIL1, NFKBIA, IL6, ARPC2, PTPRA, FES, GNAQ, CXCL6, CIITA, ITGB4, ITGB3, ITGB2, USP34, PTPN22, NUP62, CASP2, DACT1, ACTR2, ITGA2, PLAUR, SENP2, YWHAZ, DUSP22, IRF4, LCP2, LCP1, DAGLB, MET, ROCK2, LRP8, CLN3, GNG2, POLR2B, CCL5, MKNK2, IL21R, POLR2G, NCAM1, CSK, ANGPT1, EYA2, SHCBP1, TSHR, P2RX7, CD4, P2RX4, TNIP2, TSPAN17, CD9, CCM2, MNDA, KRAS, TEK, TNRC6A]
GO:1904604;negative regulation of advanced glycation end-product receptor activity;8.0;1.0;0.875;9.628524252492122;260.5223172524964;9.777073627680469;0.008719447503577626;0.875;[AGER]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, CXCL6, XBP1, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, NLRP3, IL12A, HAVCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PPP6C, C1QBP, HAVCR2, FGA, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, CLEC7A, PRDX1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[CENPJ, CEP70, RAB3IP, DCTN3, FGFR1OP, MAPRE1, TUBG1, CKAP5, CLASP1, RAB11A, PAFAH1B1]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, ANGPT1, CCL20, RYK, FGG, GPR55, CIB1, PTPN22, AGER, IGF1R, RAP1B, CD4, KARS, CCL5, KIT, CCL19, TEK, EPHA1, HRAS, MET, EPHB4, HAVCR2]
GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;1067.6044110768958;6.599019797332524;0.035731758857152955;0.7527151911823093;[SULT1A1, IMPAD1]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[CCDC88A, KIT]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[NFKBIA, RPS6KA4, MAP3K3, RPS6KA5, TNIP2, NFKB1, RELA]
GO:0043988;histone H3-S28 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;711.4828594708514;8.67846133901236;0.023812691013487215;0.8762458687964789;[RPS6KA4, RPS6KA5]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[ERN1, DVL3, RIPK1, CCL19, MAPK8IP3, AGER, ARHGEF5]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFRB, BECN1, NCF1, ANGPT1, CCL5, KIT, TEK]
GO:0006564;L-serine biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;563.0954422464521;7.8311634786251565;0.01884629769899192;0.8157270763441555;[PSAT1, SERINC3]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IL6, ARL2BP, IL23A, CCL5, KIT, IL12A]
GO:0043987;histone H3-S10 phosphorylation;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;711.4828594708514;7.9853141584524145;0.023812691013487215;0.8407982897480031;[RPS6KA4, CCNB1, RPS6KA5, VRK1]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GALC, UGT8, CLN3, ALDH5A1, KIT, GBA2]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, CSNK2A1, PARP2, SPHK1, H3F3A, DERL2, CIB1, RAB11A, SFRP1, RUFY3, FGFR1OP, ADNP, TRIM32, EIF4G2, PAFAH1B1, HBEGF]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, MYC, FUNDC1, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, ARNT, SIRT2, SFRP1, TBL2, DDIT4, HYOU1, TEK, KCNK3]
GO:2000514;regulation of CD4-positive, alpha-beta T cell activation;9.0;0.6441938053840475;0.7183375278723128;8.673012807464685;33.53549523074758;5.8067817141283475;0.0011224028453868645;0.693199712083778;[TWSG1, IL4R, IL23A, IRF4, CD80, NLRP3, NCKAP1L, IL27, CCL19, IL12RB1, AGER]
GO:0043990;histone H2A-S1 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1082.2830439947697;9.777073627680469;0.03622303949100223;0.9324289523296623;[RPS6KA5]
GO:0051923;sulfation;4.0;0.811012628672052;0.655506314336026;9.158520623246385;21.66117258152157;7.004484905440688;7.249799525138476E-4;0.6082096838060964;[SULT1A1]
GO:0015825;L-serine transport;11.0;0.8933024483968273;0.8790801765280758;9.510741216835738;156.85333935075835;7.474488534686424;0.005249740109229274;0.8146746435927894;[SLC1A4, SERINC3]
GO:0010255;glucose mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;24.962029732254507;9.083926447120524;8.354566707703096E-4;0.839552420951524;[AGER]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, NCKAP1, OXTR, DGKD, DGKA, CD80, SIRPG, IL5RA, DEFB1, IGF1R, RAB43, RPS6KA4, DOCK11, RPS6KA5, RPS6KA2, MYC, ARHGDIB, CFL1, ARL6IP5, EP300, SNIP1, NEK1, GTSE1, IFNAR2, PDGFRB, IGFBP5, PAQR3, ERN1, BCR, NISCH, DEPDC1B, KARS, DDIT4, ELMO1, KPNB1, CARD11, DIABLO, CLEC16A, ITPR2, RASGRP2, KRCC1, CRHR1, RASGRP4, STK3, RAP1B, ABR, NUAK1, CCNB1, RHOT2, RHOT1, ZMAT1, RRAS, TBXA2R, STK38, TP53BP2, DVL3, STK38L, MBP, RIPK1, ECT2, RAB6A, MARK2, CCR10, PRNP, XBP1, SETDB1, EIF2AK3, IFT122, TNFRSF10B, CNOT10, RAB27B, NFKB1, SETX, NFKBIA, CNOT4, CCDC88A, CNOT6, IRAK1BP1, COL1A2, CNOT7, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, NMUR1, CALM3, CNOT8, CALM1, RGL1, CALM2, BCAR3, BTG2, CDKN1A, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, ATP2A2, BRCA1, PKD2, BBC3, POLB, FLCN, AKAP13, AKAP11, NKIRAS1, C1QBP, CASP2, CTSH, HRAS, RAB8B, CCR2, DUSP5, KSR1, SPHK1, OXSR1, TMEM173, MASTL, GFRA2, SPTB, SIRT2, VAV1, CIT, ITPKB, GAL, TFDP1, ALS2, TFDP2, KIT, DEPDC1, TAX1BP3, PIK3C3, LCP2, ARHGEF1, LCP1, DOCK2, MET, ARHGEF5, EXOC1, HBEGF, PCNA, ROCK2, TANK, RELA, RAB21, PPP2CA, FZR1, GNG2, RAB20, PABPN1, RAB40C, CCL5, PERP, TIFA, MKNK2, NCAM1, ZNF622, RAB28, BID, E2F7, E2F8, MAP3K3, ARFGEF2, ANGPT1, CCL20, TSHR, RAB11A, SNRK, ITCH, P2RX4, TNIP2, CAMK4, RAB13, TAOK2, RAB18, CCM2, KRAS, CAMK1, TEK, ASB3, TJP2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, ANGPT1, CAV1, MTCP1, CAMK1, GFRA2]
GO:1902283;negative regulation of primary amine oxidase activity;6.0;1.0;0.8231203125901445;9.628524252492122;71.65137255504362;9.083926447120524;0.0023981069573685396;0.7876727335416686;[AOC3]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[ANGPT1, PKIA]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[ANGPT1]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[BCR, ABR, NLRP12, CUEDC2, NLRP7, PBK, NLRP3, RORA, TEK, AGER, NFKB1, IL22RA2]
GO:1904343;positive regulation of colon smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;9.777073627680469;0.00375416456595737;0.9152410118609203;[KIT]
GO:1904349;positive regulation of small intestine smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;8.67846133901236;0.00375416456595737;0.8590579283277371;[KIT]
GO:0006336;DNA replication-independent nucleosome assembly;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;163.41517932017535;6.088194173566533;0.005469358987733092;0.6863505331661754;[CENPH, H3F3A, UBN1, CENPK, POLE3, CENPL, OIP5, RBBP7, CENPP, IPO4, ITGB3BP, ASF1B]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, HIST1H2BJ, DEFB1, RNASE3, HIST1H2BC]
GO:0006335;DNA replication-dependent nucleosome assembly;8.0;1.0;0.875;9.628524252492122;163.41517932017535;7.474488534686424;0.005469358987733092;0.7572456912631272;[CHAF1B, CHAF1A, IPO4, ASF1B]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CDK9, RPS6KA4, CCNB1, RPS6KA5]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[DCTN3, KIF14, BRCA1, GPR132, CCNB1, SIN3A, RAD21, CEP70, TOPBP1, CLASP1, FANCI, DONSON, CDC7, TUBG1, CKAP5, RAB11A, CDC25A, RINT1, CENPF, RAD51C, CDK6, PKIA, CENPJ, TAOK2, CDK2, FGFR1OP, MAPRE1, PAFAH1B1]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CRTC2, DGKD, YWHAB, PKD2L1, IKZF1, PKD2, CLYBL, GLS, IGF1R, PPAT, NUP62, HRAS, PDCD6IP, KCND1, FCER1G, GPX3, ATPIF1, PRKAB1, KCTD5, GCHFR, ALDH5A1, KCTD10, KCTD14, CHMP4B, ALDOA, COLEC12, ITLN1, KCNA3, NLRC4, HSD17B8, ACACA, SPAST, RXRA, RNF213, CCL5, NLRP3, RIPK1, ECT2, BID, S100A10, VASP, POLQ, PRNP, RRM1, SEPT11, XRCC6, CPSF6, TOR1A, CAV1, EIF2AK3, P2RX7, MARCKS, COL1A2, RAD51, P2RX4, IMPDH2, TEK]
GO:0034453;microtubule anchoring;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;33.1981629444775;6.558197802812269;0.0011111126373447525;0.6585068532133508;[NIN, FGFR1OP, CLASP1]
GO:1904597;negative regulation of connective tissue replacement involved in inflammatory response wound healing;9.0;1.0;0.896240625180289;9.628524252492122;476.77945335718834;9.777073627680469;0.015957379230214893;0.896240625180289;[AGER]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, ITGB3, CD80, SIRPG, CCNF, KIF14, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, LBH, MYC, FNTB, CTSH, SOX8, IL12A, ATP7A, SKP2, HRAS, CCR2, HLA-DPA1, HAVCR2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, RUNX2, NME1, ERN1, SFRP1, CCNE2, IL23A, CCNE1, KIT, EPHA1, CARD11, HBEGF, HDAC1, FOXG1, EBI3, DERL2, NOLC1, CRIP2, THBS1, CORO1A, AGER, RELA, CCNB1, FZR1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, TBX1, MAP3K3, XBP1, CDC7, TSHR, PDCL3, CNOT6, CD4, IL6, CDK6, CNOT7, GPAM, SP1, CDK2, HLA-DPB1, FGFR1OP, KRAS, FAM98A, TEK, CNOT8, MNAT1, CCNJL]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, MAML1, CCNH, GFI1, ARID4A, RORA, YEATS4, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, PKD2, FLCN, NIPBL, SIN3A, HRAS, ZNF485, KLF13, RBM15, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, TTC5, NFIC, PSMC1, TAF7, CAMK1, MIXL1]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[ANGPT1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[BTG2, ANGPT1, WFS1, NONO, KIF14, CORO1A, CLN3, KRAS, HYOU1, ADNP, SNCB, HRAS, CPEB4]
GO:0006665;sphingolipid metabolic process;6.0;0.6073376606709605;0.6267891429256247;8.442900586834382;65.68188383398223;4.786641040901733;0.0021983135420656713;0.5679093580234316;[ELOVL5, SPHK2, AGK, SPHK1, ELOVL6, SGPP2, GBA2, PPP2CA, GALC, ALDH3A2, P2RX7, UGT8, CLN3, SGPL1, ALDH5A1, KIT, DEGS1, SERINC3, CSNK1G2]
GO:0006658;phosphatidylserine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.466005322994347;192.1199672242072;6.375876246018314;0.00643008240624912;0.6769819729871445;[PLA2G12A, SERINC3]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[PARVG, ITGB3, KIF14, TEK, EPHA1]
GO:0035774;positive regulation of insulin secretion involved in cellular response to glucose stimulus;11.0;1.0;0.9324289523296623;9.628524252492122;1297.4197001833559;6.375876246018314;0.043423469763213894;0.7584915600596062;[BAIAP3]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[MAP3K3, P2RX4, ANGPT1, SP1, ROCK2, ITGB3, CIB1, TEK, THBS1, MET]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[PRNP, NCF1, ANGPT1, ITGB3, CD80, LRP8, CD4, IL6, HSPH1, ARL2BP, IL23A, CCL5, KIT, IL12A, ADNP, HBEGF]
GO:1903033;positive regulation of microtubule plus-end binding;7.0;1.0;0.8509193652572005;9.628524252492122;62.700582840918095;9.083926447120524;0.002098532080824514;0.8154717862087246;[MAPRE3, MAPRE1]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[MAP3K3, P2RX4, ANGPT1, SP1, CIB1, THBS1]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[EIF2B4, KIT]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[ANGPT1, FBLN5]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[PDGFRB, IL5RA, ERLIN2, CLK4, CLK3, IGF1R, CLK1, BCR, WEE1, ZMYM2, FES, KIT, TRIM24, NEK1, FGFR1OP, CSK, TEK, EPHA1, MET, EPHB4, HBEGF]
GO:1905065;positive regulation of vascular smooth muscle cell differentiation;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;295.7578040146463;7.9853141584524145;0.009898747535627478;0.7833693374183408;[KIT]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[SLC12A2, CLIC5, SLC1A4, CLCC1, CLCN3, APOL1, BEST3]
GO:1902237;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;829.3805359816347;7.292166977892469;0.027758620145282933;0.7881627702307852;[SERINC3]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SMG1, IGF1R, MKNK2, TRIM24, RIPK1, CSK, MARK2, EPHB4, PDGFRB, MAP3K3, CAD, EIF2AK3, VRK1, VRK2, CLK4, EIF2S1, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, TAOK2, KIT, TEK, EPHA1, CSNK1G2]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[RIC8A, CDK5, KIT, DDHD2, CTNS, KRAS]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[KIT]
GO:0009756;carbohydrate mediated signaling;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[COLEC12, CLEC7A, AGER]
GO:0150003;regulation of spontaneous synaptic transmission;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;30.61939422688933;8.16763571524637;0.001024803569108247;0.7686126355688037;[AGER]
GO:0097324;melanocyte migration;7.0;1.0;0.8509193652572005;9.628524252492122;24.971868181253015;9.083926447120524;8.357859548042604E-4;0.8154717862087246;[KIT]
GO:0002318;myeloid progenitor cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;22.164838071467113;8.390779266560578;7.418371831928127E-4;0.7193458537639684;[KIT]
GO:0032762;mast cell cytokine production;5.0;1.0;0.7902410118609202;9.628524252492122;22.637273805675832;9.083926447120524;7.576491820522217E-4;0.7547934328124444;[KIT]
GO:0050910;detection of mechanical stimulus involved in sensory perception of sound;6.0;1.0;0.8231203125901445;9.628524252492122;83.9288867027761;7.379178354882098;0.0028090243068477775;0.7004918368257019;[KIT]
GO:0035234;ectopic germ cell programmed cell death;5.0;1.0;0.7902410118609202;9.628524252492122;49.330608194382684;7.9853141584524145;0.001651051061600959;0.6986103492792611;[KIT, CASP2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, IL23A, C1QBP, NCKAP1L, CCL19]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[ANKRD17, FGA, CXCL6, FCER1G, SEH1L, HIST1H2BJ, PPP1R11, CCL20, DEFB1, RNASE3, NLRC4, LYST, P2RX7, CD4, IL6, IL23A, BCL3, NLRP3, IL12A, HIST1H2BC, HAVCR2]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[MAP3K3, KARS, NCF1, AGER]
GO:0042744;hydrogen peroxide catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;235.80375524332874;6.481236761676141;0.007892139478392308;0.6545710619905948;[GPX3, PRDX1]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[CD4, FCER1G, SP3, BCL3, KIT, RORA, PTPN22, ATP7A, RUNX2, VAV1]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[SP3, ATPIF1, CEBPG, KIT, ACIN1, IKZF1, NFE2L1]
GO:0002327;immature B cell differentiation;7.0;0.8436909121759173;0.7727648213451592;9.420884887713877;65.04859315339267;8.16763571524637;0.002177117872910949;0.7686126355688037;[KIT]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[ZNF175, MAML1, CCNH, GFI1, EIF4A3, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, FLT3LG, PRKAB1, MED6, RUNX2, SFRP1, KARS, IL23A, RFX4, HOXB4, NOLC1, C3, FXR1, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZNF143, CREBBP, XBP1, XRCC6, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, NIPBL, C1QBP, TMED2, CTSH, HRAS, ZNF485, SEC13, NCOA6, TMEM173, PPRC1, SIRT2, GNL3, NCOR2, GAL, NCOR1, MTF2, TFEC, KIT, MAPRE3, ZNF350, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, LMNA, GPBP1L1, ZNF462, YTHDF3, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, RAB3GAP1, MIXL1, LIMS1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, YY1, EP300, ZNF564, RPS9, RPS7, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, CCNB1, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, RHBDD1, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CIITA, ONECUT2, PTPN22, DDX41, PKD2, CKS1B, RBM3, FLCN, LBH, SIN3A, NUP62, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, ITGA2, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, POLR1E, MET, HDAC3, HDAC1, WBP2, ROCK2, POLDIP3, CEBPG, THBS1, CLEC3B, U2AF2, TP53INP2, CCL5, TP53INP1, TAF1A, POLR2G, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, ARID3B, DEK, USF2, P2RX7, CD4, TNIP2, TAF7, KRAS, FAM98A]
GO:0072012;glomerulus vasculature development;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.790612467550705;8.16763571524637;9.970649894783417E-4;0.7686126355688037;[ANGPT1, TEK]
GO:0001914;regulation of T cell mediated cytotoxicity;8.0;0.7763722522362496;0.7631861261181248;9.32314260294094;59.92129984876392;6.250713103064308;0.0020055119802694153;0.6946617587785947;[P2RX7, IL23A, IL12A, HLA-A, HLA-F, IL12RB1, AGER]
GO:0010863;positive regulation of phospholipase C activity;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;83.73920694943958;6.139487467954083;0.0028026758962042993;0.6889736746265369;[PDGFRB, GNAQ, GPR55, KIT, NMUR1, HRAS, RASGRP4]
GO:0030210;heparin biosynthetic process;8.0;1.0;0.875;9.628524252492122;415.40755540718914;7.697632086000634;0.013903317036950667;0.7686572628545723;[ANGPT1]
GO:2000446;regulation of macrophage migration inhibitory factor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;9.777073627680469;0.001941286215318787;0.8509193652572005;[ANGPT1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CXCL6, ONECUT2, DOCK8, ITGB3, CIB1, IGF1R, NIPBL, C1QBP, CTSH, IL12A, ATP7A, GTSE1, HRAS, CCR2, SEMA6B, PDGFRB, IGFBP5, ITGA2, SPHK1, SWAP70, PTP4A1, CREB3, KARS, IL23A, RUFY3, KIT, EPHA1, MAPRE1, MET, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, CCL5, NCKAP1L, CCL19, CLASP1, MAP3K3, XBP1, ANGPT1, CCL20, RAB11A, VIL1, IL6, P2RX4, SP1, FGFR1OP, TEK, TRIM32]
GO:0048170;positive regulation of long-term neuronal synaptic plasticity;10.0;1.0;0.9152410118609203;9.628524252492122;315.9495864907144;8.16763571524637;0.010574548323677036;0.8329342821725234;[KIT]
GO:0071639;positive regulation of monocyte chemotactic protein-1 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.62106486279957;7.474488534686424;0.0029660672871775788;0.7331650565203278;[AGER]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[RAP1B, IGFBP5, ITPR2, SDC1, TEK, PKD2, RELA, NME1, AQP1]
GO:0006584;catecholamine metabolic process;6.0;0.7436939687323844;0.6949672969563367;9.223059144383958;80.36068301591426;6.015873511986907;0.0026895997406233426;0.6307723637598831;[SULT1A1, MTPN, MOXD1, ATP7A, COMT, SNCB]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, CIITA, BTG2, ZNF175, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, SIN3A, C1QBP, MYC, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, SOX6, JARID2, ZNF564, DACT1, TLE4, KLF11, KLF12, PEG3, RFC1, ZBTB32, ARID1A, HCFC2, SIRT2, ZFP90, DUSP22, NCOR2, EID1, BRMS1, NCOR1, RBL1, TBL1XR1, CCNE1, NFX1, MTF2, HOXB4, TIMELESS, LCOR, PPID, MCPH1, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, DNAJB5, TPR, HIVEP1, HESX1, SUDS3, RBBP7, MTA2, E2F7, ZNF189, E2F8, BPTF, IRX1, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, WFS1, CAV1, NFKB1, PER2, GFI1B, CNOT7, NFIA, CNOT1, NFIB, NFIC, PKIA, SP3, CDK2, NFE2L3, TAF7, ZNF136, EZH2]
GO:0051225;spindle assembly;7.0;0.7508913569872202;0.7263650437508107;9.168991923113682;86.84099814437;5.266214121163619;0.00290649005606778;0.6202338003175094;[HDAC3, NCOR1, TUBGCP2, ZNF207, MAPRE3, FBXO5, MAPRE1, TUBG1, KPNB1, CLASP1, RAB11A]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[ERRFI1, EIF4A3, CIB1, RORA, GPATCH3, IGF1R, RGS1, MYC, WWC3, HOMER3, EPHB4, TLE4, PDGFRB, IGFBP5, ARRDC1, PAQR3, SLC35C1, RUNX2, PIAS2, SFRP1, TWSG1, RFX4, DDIT4, PPIF, VDAC2, EPHA1, KLHL12, APCDD1, AGER, GLG1, STK3, RNF213, HSPH1, STK38, DVL3, NLRP3, RIPK1, PRNP, PRELID1, XBP1, UBE2B, AMBP, WFS1, NONO, CAV1, IFT122, TNFRSF10B, TNFRSF10A, ARHGAP25, NFKBIA, IL6, NPLOC4, CNOT7, QARS, CNOT1, BCL3, CALM3, CRIPAK, HYOU1, CALM1, CALM2, EZH2, ONECUT2, YWHAB, OTUD7B, PTPN22, BRCA1, PKD2, DUSP14, FLCN, LBH, C1QBP, NUP62, PBK, HIF1AN, DACT1, FGA, DUSP5, PVRIG, FGG, PLAUR, SENP2, DUSP22, CREB3, NCOR1, IRF4, KIT, TAX1BP3, CHMP6, MET, PAFAH1B1, HDAC3, HIST1H2BJ, HDAC1, MGRN1, LILRA2, THBS1, TANK, RELA, ARNTL, PPP2CA, SNX25, CCL5, LMNA, UBQLN1, CSK, RFFL, BID, EYA2, RYK, SYVN1, P2RX7, ITCH, NLRP12, PIK3IP1, TEK, TRIM32]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[SFRP1, XRCC5, MTF2, KIT, HOXB4, A2M, JARID2, RUNX2]
GO:1990502;dense core granule maturation;7.0;1.0;0.8509193652572005;9.628524252492122;31.399434805935044;8.67846133901236;0.001050910825297963;0.7947362817240173;[SNX19, BAIAP3]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[SETX, BECN1, IL6, PCNA, PPIF, ECT2, RELA, EZH2, AQP1]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[MKLN1, PARVG, KIT]
GO:0050930;induction of positive chemotaxis;8.0;1.0;0.875;9.628524252492122;129.39753142075796;7.138016298065211;0.004330818926435078;0.7400384854347593;[AGER]
GO:1905413;regulation of dense core granule exocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;65.38105427470538;9.777073627680469;0.0021882450474457016;0.9152410118609203;[BAIAP3]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ASF1B, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, ZNF136, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, JARID2, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF101, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, PHTF2, CIITA, ONECUT2, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3B, POLR3C, TNIP2, POLR3E, TAF7, MNDA, TAF5]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[TCERG1, ZNF175, MAML1, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SFMBT2, FLT3LG, HCFC2, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, KARS, IL23A, EWSR1, RFX4, BOLA3, HOXB4, TRIM14, ASF1B, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, COMMD9, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, H3F3A, PBX3, EIF2AK3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, QARS, GOLGB1, PKIA, ZNF30, ZNF136, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, ATF7IP2, OTUD7B, HOXC13, ZNF45, BRCA1, WASL, AATF, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, JARID2, HRAS, HAVCR2, ZNF485, TSC22D4, HELLS, SEC13, NCOA6, SPHK1, PRMT3, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, VAV1, MED28, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, DEPDC1, MAPRE3, VGLL4, ARHGEF5, ZNF350, PCNA, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, SERTAD2, UBN1, GPBP1L1, SCAND1, ZNF101, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, LIMS1, ZNF331, CRTC2, NCF1, NAB1, CD80, GMNN, ARID4A, UBP1, CIB1, RORA, YEATS4, YY1, ADORA3, WWC3, ZNF207, EP300, SNIP1, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, PIAS2, ERN1, ARMCX3, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, CARD11, ZNF550, MAX, RLF, SUPT6H, AGER, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, PRNP, DR1, UBE2I, WFS1, NONO, CAV1, CNOT10, NFKB1, CDK9, NFKBIA, CNOT6, IRAK1BP1, IL6, TFCP2, COPS5, CNOT7, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, CNOT8, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, USP36, PHTF2, CIITA, ONECUT2, YWHAB, ITGB2, DDX41, PKD2, CHD1, AFF4, CKS1B, FLCN, LBH, SIN3A, ZNF407, NUP62, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, MET, ZNF630, ITGB3BP, MCPH1, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, NLRC4, LRP8, TFPT, RBBP5, DNAJB5, TP53INP2, FAM120B, TP53INP1, TAF1A, ASCC3, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, RNF20, CHURC1, EYA2, FBXL15, ARID3B, DEK, USF2, CD4, POLR3C, TNIP2, TAF7, MNDA, KRAS, TAF5, TRIM32]
GO:0038162;erythropoietin-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.390779266560578;0.00101047745553359;0.7800242071602487;[KIT]
GO:0002551;mast cell chemotaxis;8.0;1.0;0.875;9.628524252492122;95.22538104108446;8.16763571524637;0.0031871078061660985;0.7926932703116032;[KIT]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, IER2, ZNF282, FLT3LG, HCFC2, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, ZNF260, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, ZNF136, EZH2, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, NIPBL, ZMYM2, C1QBP, CIC, JARID2, HRAS, HAVCR2, ZNF485, TSC22D4, NCOA6, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, ZNF350, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, UBN1, ZNF101, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, RORA, YEATS4, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BAG3, TPR, ZNF549, ZNF548, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, WFS1, NONO, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, ZNF658, NFE2L3, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, ONECUT2, DDX41, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, DNAJB5, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, FBXL15, ARID3B, DEK, USF2, TNIP2, TAF7]
GO:0010849;regulation of proton-transporting ATPase activity, rotational mechanism;9.0;1.0;0.896240625180289;9.628524252492122;118.7690364191278;9.777073627680469;0.003975092763755005;0.896240625180289;[PPIF]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[IL23A, CCL19, AGER, RELA]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[KIT]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCL6, CCL20, CCL5, CIB1, CCL19, CCR10, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, PPIF, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, HSPH1, BAG3, BAG1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, WFS1, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, BTG2, CDKN1A, DOCK8, KIF14, BRCA1, AATF, NNT, SIN3A, NUP62, CASP2, CTSH, HRAS, TSC22D4, FGA, DFFA, FCER1G, SPHK2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, PTRH2, KIT, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, TBX1, ANGPT1, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, PCNA, NCF1, ATP2A2, PKD2, RELA, AQP1, PRDX1, TP53INP1, ECT2, GPX3, TXNRD1, GPX7, PYCR1, VRK2, EIF2S1, SIRT2, SETX, IL6, CCS, PXMP2, CDK2, PPIF, NFE2L1, EZH2]
